Environmental Protection Agency (EPA) to announce plan on strengthening regulations against certain chemicals; risk of emergency complications increased in pregnant women with symptomatic COVID-19; fully vaccinated, heavy marijuana users with substance abuse disorder linked with higher susceptibility to breakthrough infection.
As reported by The Hill, the Environmental Protection Agency (EPA) is set to announce a plan that would strengthen regulations against toxic chemicals known to disproportionately impact vulnerable populations. Polyfluoroalkyl compounds, or PFAS, have been linked with adverse health outcomes such as kidney and testicular cancer, and a 2015 study showed PFAS to be in the blood of 97% Americans. A spokesperson of the EPA confirmed that it has engaged with the Department of Defense in its effort to curb PFAS, but no steps were noted on whether this included steps to address PFAS from military bases—a major source of the contamination.
According to 2 new studies, risk of emergency complications may be increased in pregnant women who develop COVID-19–related symptoms, which would also put their children at risk, CNN reported. The study found that 58% of COVID-19–positive mothers with symptomatic infections delivered in emergency circumstances, compared with 46% of mothers who had asymptomatic COVID-19 infections. Notably, infants born to symptomatic mothers were shown to be significantly more likely to require oxygen support and be admitted to the intensive care unit.
People with substance abuse disorder (SUD) who are fully vaccinated against COVID-19, particularly heavy marijuana users, were indicated to be more susceptible to breakthrough cases of the virus. Reported by Fox News, findings of the study published in World Psychology found that patients with SUD, including a dependence on marijuana, alcohol, cocaine, opioids, and tobacco, were at nearly 2 times greater risk of breakthrough infections compared with those without SUD (7% vs 3.6%), with patients who had marijuana use disorder most at risk (7.8%). Marijuana advocates said the findings did not show that the drug could be a cause in breakthrough cases, and noted that most users are not dependent on marijuana.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More